Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Toda
In trading on Thursday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) crossed below their 200 day moving average of $31.22, changing hands as low as $30.53 per share. Apellis Pharmaceuticals Inc shares are currently trading down about 1.5% on the day. The chart below
In trading on Thursday, shares of Industrial Logistics Properties Trust (Symbol: ILPT) crossed below their 200 day moving average of $20.42, changing hands as low as $19.03 per share. Industrial Logistics Properties Trust shares are currently trading off about 6.2% on the day
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on June 2, CME Group's Director, William R. Shepard, invested $137,315.10 into 771 shares of CME, for a cost per share of $178.10. Bar
In trading on Thursday, shares of Tabula Rasa HealthCare Inc (Symbol: TRHC) crossed below their 200 day moving average of $52.94, changing hands as low as $52.77 per share. Tabula Rasa HealthCare Inc shares are currently trading down about 5% on the day. The chart below show
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Micron Technology Inc. (Symbol: MU), where a total volume of 133,144 contracts has been traded thus far today, a contract volume which is representative of appr
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Starbucks Corp. (Symbol: SBUX), where a total volume of 92,741 contracts has been traded thus far today, a contract volume which is representative of approximat
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Procter & Gamble Company (Symbol: PG), where a total of 33,314 contracts have traded so far, representing approximately 3.3 million underlying shares. That amounts
Bristol-Myers BMY announced that the FDA has approved blockbuster immuno-oncology drug, Opdivo, for yet another indication.The drug is now approved for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after p
At the recently held Federal Reserve meeting, it was reiterated that the Fed funds rate will stay in the 0-0.25% range for the foreseeable future. The central bank authorities also stated that it will keep on raising its bond holdings, targeting Treasury purchases at $80 billion
In trading on Thursday, shares of Itochu Corp (Symbol: ITOCY) crossed below their 200 day moving average of $43.05, changing hands as low as $42.60 per share. Itochu Corp shares are currently trading off about 2% on the day. The chart below shows the one year performance of
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
Asbury Automotive Group (ABG) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.
Clearwater Paper (CLW) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.
Investors might want to bet on Soleno Therapeutics, Inc. (SLNO), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.
Chewy (CHWY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Checked
6 minutes 28 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks